NCT05850949

Brief Summary

determine the effect of giving the Konjac-Grain formula as a mixture of white rice in suppressing post-prandial glucose absorption.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 29, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 9, 2023

Completed
1 day until next milestone

Study Start

First participant enrolled

May 10, 2023

Completed
6 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 16, 2023

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2023

Completed
Last Updated

May 9, 2023

Status Verified

April 1, 2023

Enrollment Period

6 days

First QC Date

March 29, 2023

Last Update Submit

May 8, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change Post prandial blood glucose

    Without supplementation, followed by Supplementation with Dietary Fibre the Konjac-Grain week 1, repeated until week 6, blood collected 2 hours after meals with a 3" fine needle 10ml Citrat-Tube blood Glucose (mg/dl or mmol/L) one drop (50microliter) of blood from citrat-Tube was transferred to the Glucose test strip. Glucose was measured with disposable 'test-strip', which is then inserted into an electronic blood glucose meter (device: Accu-Check Instant S Glucose from Roche) . Normal value:70 to 99 mg/dL (3.9 to 5.5 mmol/L).

    2 hours after meals.

  • Change Post prandial blood HbA1c

    Without supplementation, followed by Supplementation with Dietary Fibre the Konjac-Grain week 1, repeated until week 6, blood collected 2 hours after meals with a 3" fine needle 10ml Citrat-Tube blood HbA1c (mg/dl) one drop (50microliter) of blood from citrat-Tube was transferred to the HbA1c test strip. HbA1c was measured with disposable 'test-strip', which is then inserted into an electronic blood glucose meter (device: Accu-Check Instant S HbA1c from Roche) . Normal value:80-180 mg/dL

    2 hours after meals.

Study Arms (1)

Konjac-Grain

EXPERIMENTAL

Without supplementation, followed by Supplementation with Konjac grain from PT. AMBICO

Dietary Supplement: Konjac Grain

Interventions

Konjac GrainDIETARY_SUPPLEMENT

Without supplementation, followed by Supplementation with Dietary Fibre the Konjac-Grain week 1, repeated until week 6, blood collected with a fine needle 10ml citrate-Tube Glucose was measured with disposable 'test-strip', which is then inserted into an electronic blood glucose meter (device: Accu-Check Instant S Glucose from Roche) . Normal value:70 to 99 mg/dL (3.9 to 5.5 mmol/L). Further HbA1c (glycated Hemoglobin A1c) concentration was checked with disposable 'test-strip', which is then inserted into an electronic HbA1c meter (device: Accu-Check Instant S HbA1c from Roche). Unit value fir HbA1c = mg/dl

Konjac-Grain

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy male or female, aged 18-50 years
  • Not currently taking any medication
  • Do not have a history of metabolic diseases such as hypertension, prediabetes, metabolic syndrome, non-alcoholic fatty liver disease (NAFLD) previously from the results of doctor and laboratory examinations.
  • Agree to be included as a research subject (by signing an informed consent)

You may not qualify if:

  • Was experiencing an acute infectious disease at the time of the study
  • Lack of sleep or heavy physical activity during the study
  • Subjects experienced pregnancy during the study
  • Subjects withdrew at any time during the research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitas Katolik Widya Mandala Surabaya

Surabaya, East Java, 60112, Indonesia

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: Repeated single arm
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Clinical Pharmacology research laboratories

Study Record Dates

First Submitted

March 29, 2023

First Posted

May 9, 2023

Study Start

May 10, 2023

Primary Completion

May 16, 2023

Study Completion

May 31, 2023

Last Updated

May 9, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Share after publication

Locations